Project Grant HT94252410250
Award Date
5/1/24
Completion Date
4/30/27
Dollars Obligated
$829K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90089, USA
Similar Awards
The University of Southern California (USC) was awarded a $3,296,634.00 Project Grant from the Defense Health Agency to conduct research on "ACTIVATION OF BRAIN LYMPHATIC DRAINAGE THROUGH PIEZO1-CONTROLLED MECHANOTRANSDUCTION AS A NOVEL HYDROCEPHALUS THERAPY". The grant, which commenced on September 1, 2023 and will be completed by August 31, 2027, is funded through the Military Medical Research and Development (CFDA 12.420) program. This research aims to investigate medical...
The University of Southern California (USC) Department of Contracts and Grants Division was awarded a $331,630 Project Grant by the Defense Health Agency under the "Military Medical Research and Development" (CFDA 12.420) program. The grant supports research into mRNA delivery for polycystic kidney disease, with a period of performance from November 15, 2023 to November 14, 2025. As a leading private research university, USC leverages its expertise in engineering, health sciences,...
The University of Southern California (USC) received a $1,992,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, effective September 15, 2025 through September 14, 2028, is for the development of a "Synthetic Immune Receptor for the Treatment of Prostate Cancer". The Military Medical Research and Development program supports advanced biomedical research aimed at transforming...
The University of Southern California will receive $1,209,550 under a three-year Project Grant award from the Department of the Army Medical Command. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to improve health care for service members and the public. Specifically, USC will develop wearable early intervention electric stimulation technology for optic nerve regeneration. The...
The University of Southern California will receive $330,000 under a two-year Project Grant award from the Department of the Army Medical Command. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to improve military and public health care. Through this funding, USC will validate PIKFYVE inhibition as a therapeutic approach for diverse forms of frontotemporal dementia from March 2021 to...
This Project Grant award from the Defense Health Agency provides $329,998 to the University of Southern California for airway reconstruction via stem cell-based therapy. The award is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative solutions for battlefield medicine. The University of Southern California will conduct research and...
The University of Southern California (USC) was awarded a $915,936 Project Grant from the U.S. Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The funding supports research to investigate SETD2 deficiency as a therapeutic target to upregulate viral mimicry for treating aggressive clear cell renal cell carcinoma in patients. This award is part of the program's focus on cancer, neurological disorders, and other health...
The federal Project Grant award, valued at $2,490,000.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is for the "Development of a VAV2 Antisense Oligonucleotide Therapeutic for ALS" at the University of Southern California (USC). This award, effective March 1, 2025 through February 28, 2027, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
The Department of Defense awarded a $3,166,177 Cooperative Agreement to the University of Southern California (USC) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2023. This funding supports the "Convergent Science Cancer Consortium" project, which aims to transform healthcare for Service Members and the American public through innovative biomedical research on cancer and other disease areas. As part of this effort, USC has sub-awarded...
This federal Project Grant award in the amount of $747,507 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports an evaluation of an engineered calpain activity nanosensor in a mouse model of traumatic brain injury (TBI) at the University of California, San Diego (UCSD). The objective of the research is to advance the development of innovative technologies for monitoring and assessing traumatic brain injuries,...